Editorial
 THE ACTION ON SEMLER   
 Wednesday, May 04, 2016 
 Data integrity issue has been a matter of serious concern for India’s top pharmaceutical companies for some years now affecting their exports to the US and European Union, the two key export destinations of generic drugs. 
  Past Editorial...  
TODAY'S NEWS
15:00  [IST]AstraZeneca divests Imdur to China Medical System
14:30  [IST]ICGEB, Sun Pharma collaborate to develop botanical drug for dengue
14:00  [IST]Allergan launches initiative to help US military servicewomen access IUD Liletta
13:00  [IST]Roche to present new results from 19 personalised medicines & cancer immunotherapies at ASCO annual meeting in Chicago
12:45  [IST]ARTIST kicks off campaign to tackle Gestational Diabetes Mellitus among pregnant women
12:20  [IST]Manipal Health Enterprises appoints Sameer Aggarwal as CFO
more news >>
TOP NEWS
08:00  [IST]DST to begin research in area of cognitive science under CSR initiative
08:00  [IST]NIB's new version of software for HvPI to capture more data on blood transfusion reactions
08:00  [IST]MBBS students exempted from compulsory rural service in Telangana
08:00  [IST]AIOCD urges NPPA to mandate cos to recall stock from trade for correction in MRPs
08:00  [IST]Cigna TTK Health Insurance plans to enhance presence in 15 more cities
08:00  [IST]Task Force asks govt to create vision document with short & long term plan for plasma industry
more news >>
YESTERDAY'S NEWS
18:00  [IST]US FDA approves first generic Crestor
17:00  [IST]Accuray, medPhoton ink pact for CyberKnife System
16:00  [IST]US FDA approves Acadia Pharma's Nuplazid to treat hallucinations, delusions associated with Parkinson’s disease
15:50  [IST]Rajnibhai V Patel Trust organises 'PharmaInnova Award' event for pharmacy students
15:30  [IST]Veristat acquires UK-based CRO Spero Oncology
15:00  [IST]US FDA approves Teva's ProAir RespiClick inhalation powder for paediatric asthma patients aged 4-11 yrs
more news >>
INTERVIEW  
Need for screening patients with high risk of aortic disease: Tony Semedo
Medtronic Tony Semedo, Senior vice president
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the ban on 344 FDC drugs by the Union Health Ministry came all of a sudden as is being argued by the industry?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |